Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.20 – $1.28
13% from low
Exchange
OTC Link
CS
Borrow rate
3.53%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $376.7K | $240.3K | $122.6K | $48.3K | $213.8K | $89.2K | $7.7K | $797.2K |
| Cost of revenue | $171.0K | $81.7K | $95.9K | $5.9K | $15.3K | $36.0K | $1.7K | $105.9K |
| Gross profit | $205.7K | $158.6K | $26.7K | $42.4K | $198.6K | $53.2K | $6.0K | $691.4K |
| Gross margin | 54.6% | 66.0% | 21.8% | 87.8% | 92.9% | 59.6% | 78.3% | 86.7% |
| R&D | $151.8K | $1.1M | $4.3M | $1.6M | $1.5M | $891.1K | $1.5M | $1.8M |
| Operating income | −$4.6M | −$4.5M | −$3.0M | −$4.5M | −$2.9M | −$3.8M | −$5.1M | −$4.8M |
| EBITDA | −$4.6M | −$4.3M | −$2.8M | −$4.5M | −$3.1M | −$2.7M | −$3.6M | −$2.6M |
| Net income | −$6.5M | −$7.7M | −$4.0M | −$5.8M | −$4.4M | −$3.8M | −$5.1M | −$3.4M |
| Net margin | -1728.9% | -3208.3% | -3274.3% | -12021.8% | -2043.3% | -4224.9% | -66616.1% | -431.5% |
| EPS (diluted) | -2.60 | -2.19 | -0.75 | -0.89 | -0.61 | -0.45 | -0.49 | -0.19 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $971851 | $-0.21 | $-0.21–$-0.21 | 1 |
| 2027 | $1M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
BIOCORRX INC NEW
No one on the platform currently holds BICX.
No tracked institution reports a position in BICX as of their last filing.
| Execution date | Ratio |
|---|---|
| 2019-01-22 | 1-for-100reverse |
| 2010-08-13 | 200-for-1 |
No one on the platform has traded BICX yet.
| $9M |
| — |
| IONKFIonic Brands Corp. | $0.00 | +0.00% | $1592 | — |
| LOBEFLobe Sciences Ltd. | $0.01 | +0.00% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 23.1× sales vs its 148.6× historical median P/S.
Fair value ≈ $2.18 · price $0.34 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.